| Tag | Content |
|---|
EnhancerAtlas ID | HS059-46397 |
Organism | Homo sapiens |
Tissue/cell | GM12878 |
Coordinate | chr8:131154680-131156310 |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| NEUROG2 | MA0669.1 | chr8:131155671-131155681 | GACATATGTT | - | 6.02 | | NR3C1 | MA0113.3 | chr8:131155351-131155368 | AGGGACACATTGTTCCT | - | 6.01 | | NR3C1 | MA0113.3 | chr8:131155351-131155368 | AGGGACACATTGTTCCT | + | 6.07 | | NR3C2 | MA0727.1 | chr8:131155351-131155368 | AGGGACACATTGTTCCT | - | 6.08 | | NR3C2 | MA0727.1 | chr8:131155351-131155368 | AGGGACACATTGTTCCT | + | 6.11 | | PRDM1 | MA0508.2 | chr8:131155587-131155597 | TCACTTTCAC | + | 6.02 |
|
| | Number of super-enhancer constituents: 3 | ID | Coordinate | Tissue/cell |
| SE_09147 | chr8:131154390-131157584 | CD14 | | SE_52284 | chr8:131153465-131157593 | Skeletal_Muscle_Myoblast | | SE_64162 | chr8:131153434-131157718 | HSMM |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 2 | Chromosome | Start | End |
| chr8 | 131155200 | 131155691 | | chr8 | 131155847 | 131156153 |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH08I130140 | chr8 | 131152775 | 131158035 |
|
Enhancer Sequence | AATTTTAGAA GCCACTTTGA AATTCCTACT TACTCATTCA TCATATATTT ATTAAGTCTC 60
TACCACATTC CAAGCACATC TGAGAAACAC ATGGTCCATG CCATTAAACA TCTGTGGAAA 120
CAGACTTGAT TACGTATGGG GGCCCAGGGA GCCCAGGGAC CTGAGCTCAA GGGTGTGCAC 180
CAAAGATGTA GGCAAGGTTC CACACAGGCA GCCTCAACCT TCAGAGAGGA CTTGGAGGAG 240
GGAATATGGA CAAACTGGGA AGTGTGATAA GCAGGTCCAA AGGCCTGGGG CATAGGAGGG 300
GACAAGCTGC AGGAGGTGAC ACTGAGCACA CAGGAAGGGA GACTCTGCAT ATGATACTAA 360
GAAACTCACA TTCCTATCCA TGACTCTGGC AATCTACTGG AGAAAGCAGA GTGGCCAGTT 420
AGATCTCTAT TTCACGGTGG GGTGGTGGGG GGGCAGTTGG TGGGAAAGGT AGAGGAGGCA 480
GAGAGAGGCT GAGAGAGTAA GGAAGATGAG CAATGAAATG AGGAGGGCCT GAATTAGAGC 540
TACGTACGGT AGTGGTGCTG GTGGCCAGAG GCTTAAGACA GCTAGAAAAG GAGACTTTCA 600
ATGCATCATT CCACAAGTAA TCATTACCTA CTATGTGAAT TATTCAGTGC AGAAATTTGA 660
ATGGTGAATG GAGGGACACA TTGTTCCTGA AGGCTGTCTT GAGCAGCATC TCTTTCAAAA 720
GCTACAAGAG CTTCTCTAAA TATAGTTATG ACACTTTTCA AAGCTGACAA TTCTACAACT 780
CTGTTCCTTC AAACTCTGAG GCTTGTCCTT TTATAGGTTT CACTTCTCAT TAAAATAAAA 840
CACATTCATA GAAGAAAAGG AGACAGAGAT AGTACAAAGA AGAAACCAAA CATTAGTTGT 900
TGGAATCTCA CTTTCACATG CAGCAATAAT CACTGTTAAT ACCTTAATTT TACCAAGATG 960
TGTGTGTGAG ATGTCTGTTT TTTTTTTTTT TGACATATGT TGGTTCAACT TGTATATACT 1020
ATTTTGTAAA CTGTTTTTCC CAATTAACAA TATACACAGA TGTCTTCATT TTACACACCC 1080
CTCTCCTACA CACCCTCAGA CAAAAGGCAA ACCTATTCAA GTTTTTGATT TTTGAAAATG 1140
TTTCAATCAG GGAAGCTCTG GGTACATTTC ATGAAGAGAA GTGATGAAGA TATCCCTCTG 1200
ACATAACAGA AAGTGGCTGT TTAGCTAGGA AAATCATCAA ATAAGTAAGT AGAAATGCAT 1260
GCAGAAACAG AATGAGTCAA TCCCAATTAA TGTTTCTGTG TTTCCTAAAA GAAAATAAAC 1320
ACCGCACATT TGTCTTTAGA CAGCTTAGTG TGCACCATGG TTCCAGTGTT TTTGCTGGAA 1380
GTGTAAAGTT GTTAGCACAG GCATATTTCT CAGTTAGCAG AAAACAGCTG CTACTGGAAT 1440
TAGTACCCAG AAATGAAATT ATTTCCTCCC ATCATCTTAC TGAATTGCTC TGCTTTACAA 1500
ACAAGAAGTG AACATTAATT ACTTGGAAAA TAGGCCTGAC CCAGCCAGGA TGAGGCTGAC 1560
GCGTGGAAAG AGGTAAAAAT AAAATGACAA AGCTCTCTTC ACTTCCTATG CTAGTGTCTG 1620
AAAACAGAGC 1630
|
